
What smart money is saying about Avanos Medical
1 fund in our archive has pitched Avanos Medical — most recently Diamond Hill Small Cap Fund in March 2025.
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Get an email when a fund writes about it
Position history
Between Q1 2025 and Q2 2026, 1 fund letter reported a position in Avanos Medical — 1 trimmed or exited.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 1 | 0 |
| Q1 2025 | 0 | 0 | 0 | 1 |
Fund activity · 1 position · 1 move
- ExitedLaughing Water Capital (LW Capital Management, LLC)June 2026
“The two investments in question were Theravance Biopharma (TBPH) and a position which I did not disclose at the time.”
Read the letterAvanos Medical
Fund coverage · 1 thesis
- Diamond Hill Small Cap FundMarch 2025
Avanos Medical is a promising investment opportunity due to its innovative product offerings in pain management and respiratory health, recent cost-cutting efforts, and strong growth potential under new leadership.
Read the full thesis
Read every full thesis on Avanos Medical
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→